| Literature DB >> 35613769 |
Sujarwoto Sujarwoto1, Asri Maharani2.
Abstract
OBJECTIVES: This study aims to examine sociodemographic characteristics and health access associated with COVID-19 infection and death in Malang District, Indonesia.Entities:
Keywords: COVID-19; epidemiology; public health
Mesh:
Year: 2022 PMID: 35613769 PMCID: PMC9130669 DOI: 10.1136/bmjopen-2021-052042
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Malang District East Java Indonesia.
Figure 2Procedure for COVID-19 tracing and testing. ODP, Orang Dalam Pemantauan; OTG, Orang Tanpa Gejala; PDP, Pasien Dalam Pengawasan; RT-PCR, reverse transcription PCR; TCM, Test Cepat Molekuler
Sample characteristics of all tracked individuals and COVID-19 confirmed cases
| Variables | All sample (n=14 264) | COVID-19 confirmed cases (n=551) | ||||||
| % or mean | SD | Min | Max | % or mean | SD | Min | Max | |
| COVID-19 infections | 551 (3.9%) | 551 (100%) | ||||||
| COVID-19 deaths | 62 (0.4%) | 62 (11.3%) | ||||||
| Male | 9109 (63.9%) | 293 (53.2%) | ||||||
| Age, years | ||||||||
| 1794 (12.6%) | 33 (6.0%) | |||||||
| 9049 (63.6%) | 218 (39.6%) | |||||||
| 2766 (19.4%) | 214 (38.8%) | |||||||
| 632 (4.4%) | 86 (15.6%) | |||||||
| Job type | ||||||||
| 62 (0.4%) | 14 (2.5%) | |||||||
| 58 (0.4%) | 12 (2.2%) | |||||||
| 59 (0.4%) | 5 (0.9%) | |||||||
| 4092 (28.7%) | 347 (63.0%) | |||||||
| 2349 (16.5%) | 295 (53.5%) | |||||||
| 2265 (15.9%) | 37 (6.7%) | |||||||
| 2085 (14.6%) | 170 (30.9%) | |||||||
| 2864 (20.0%) | 42 (7.6%) | |||||||
| 227 (1.6%) | 25 (4.5%) | |||||||
| Had contact with confirmed COVID-19 case | 512 (3.6%) | 159 (28.9%) | ||||||
| Had contact with suspected COVID-19 case | 354 (2.5%) | 92 (16.7%) | ||||||
| Visited animal market | 14 (0.1%) | 1 (0.2%) | ||||||
| Symptoms | ||||||||
| 983 (6.9%) | 212 (38.5%) | |||||||
| 1200 (8.4%) | 178 (32.3%) | |||||||
| 549 (3.8%) | 58 (10.5%) | |||||||
| 288 (2.0%) | 40 (7.3%) | |||||||
| 640 (4.5%) | 147 (26.7%) | |||||||
| 121 (0.8%) | 17 (3.1%) | |||||||
| 180 (1.3%) | 30 (5.4%) | |||||||
| 457 (3.2%) | 76 (13.8%) | |||||||
| 133 (0.9%) | 21 (3.8%) | |||||||
| 241 (1.7%) | 55 (10.0%) | |||||||
| 113 (0.8%) | 20 (3.6%) | |||||||
| 68 (0.5%) | 14 (2.5%) | |||||||
| Having at least one symptom | 1824 (12.8%) | 299 (45.7%) | ||||||
| Presence of comorbidities | ||||||||
| 2026 (14.2%) | 267 (48.5%) | |||||||
| 80 (0.6%) | 8 (1.5%) | |||||||
| 3213 (22.5%) | 333 (60.4%) | |||||||
| 19 (0.1%) | 4 (0.7%) | |||||||
| 15 (0.1%) | 2 (0.4%) | |||||||
| 32 (0.2%) | 4 (0.7%) | |||||||
| Medical doctor diagnosis before RT-PCR | ||||||||
| 648 (4.5%) | 222 (40.3%) | |||||||
| 23 (0.2%) | 7 (1.3%) | |||||||
| Respiratory failure | 0.8% | 11 (2.0%) | ||||||
| Inpatient | 5.8% | 276 (50.1%) | ||||||
| intensive care unit | 0.2% | 6 (1.4%) | ||||||
| Village determinants | ||||||||
| 134 | 20 | 0 | 149 | 111 | 41 | 0 | 147 | |
| 11 | 5 | 3 | 32 | 14 | 6 | 4 | 32 | |
| 10 | 9.1 | 0.0 | 43.0 | 3.9 | 4.6 | 0.0 | 36.5 | |
| 8 | 9 | 0 | 69 | 13 | 14 | 1 | 69 | |
| 0.2 | 0.04 | 0.01 | 0.4 | 0.2 | 0.05 | 0.03 | 0.3 | |
| 34.2 | 16.0 | 1.0 | 79.0 | 18.8 | 10.0 | 4.0 | 68.0 | |
| 390 | 152 | |||||||
RT-PCR, reverse transcription PCR.
Unadjusted and adjusted multilevel logistic regressions for COVID-19 infection (N individual=14 264, N village=152)
| Variables | Unadjusted OR | 95% CI | P value | Adjusted OR | 95% CI | P value |
| Individual determinants | ||||||
| Age, years, reference: 17 years and younger | ||||||
| 2.09 | 1.39 to 3.15 | <0.001 | 0.83 | 0.36 to 1.95 | 0.673 | |
| 5.05 | 3.33 to 7.66 | <0.001 | 1.02 | 0.41 to 2.55 | 0.968 | |
| 5.36 | 3.34 to 8.63 | <0.001 | 1.14 | 0.43 to 3.03 | 0.799 | |
| 0.70 | 0.57 to 0.85 | <0.001 | 0.74 | 0.56 to 0.98 | 0.033 | |
| Job type, reference: health worker | ||||||
| 9.30 | 3.93 to 22.00 | <0.001 | 6.09 | 0.44 to 85.18 | 0.180 | |
| 0.45 | 0.16 to 1.23 | 0.122 | 0.37 | 0.05 to 2.76 | 0.330 | |
| 1.17 | 0.80 to 1.71 | 0.413 | 0.42 | 0.13 to 1.38 | 0.153 | |
| 1.51 | 1.03 to 2.21 | 0.032 | 0.39 | 0.12 to 1.26 | 0.115 | |
| 1.45 | 0.94 to 2.22 | 0.086 | 0.37 | 0.11 to 1.27 | 0.113 | |
| 1.87 | 1.47 to 2.38 | <0.001 | 0.42 | 0.13 to 1.38 | 0.153 | |
| 0.32 | 0.23 to 0.44 | 0.000 | 0.17 | 0.05 to 0.66 | 0.011 | |
| 3.18 | 2.08 to 4.86 | 0.000 | 0.22 | 0.06 to 0.81 | 0.023 | |
| 12.98 | 9.36 to 18.00 | <0.001 | 20.56 | 12.96 to 32.62 | 0.000 | |
| 5.19 | 3.63 to 7.43 | <0.001 | 0.86 | 0.51 to 1.47 | 0.583 | |
| 1.06 | 0.09 to 11.85 | 0.960 | 0.10 | 0.01 to 1.23 | 0.072 | |
| Symptoms | ||||||
| 2.59 | 2.04 to 3.29 | <0.001 | 2.68 | 1.95 to 3.71 | 0.000 | |
| 1.02 | 0.80 to 1.31 | 0.823 | 0.85 | 0.58 to 1.23 | 0.386 | |
| 0.59 | 0.42 to 0.83 | 0.003 | 0.80 | 0.51 to 1.27 | 0.343 | |
| 0.83 | 0.55 to 1.24 | 0.382 | 0.78 | 0.46 to 1.30 | 0.334 | |
| 2.27 | 1.74 to 2.96 | <0.001 | 3.03 | 2.11 to 4.36 | 0.000 | |
| 0.97 | 0.53 to 1.80 | 0.948 | 0.58 | 0.27 to 1.25 | 0.165 | |
| 1.58 | 0.97 to 2.58 | 0.062 | 1.26 | 0.70 to 2.27 | 0.439 | |
| 1.81 | 1.30 to 2.50 | <0.001 | 0.72 | 0.47 to 1.12 | 0.151 | |
| 1.60 | 0.88 to 2.88 | 0.118 | 0.89 | 0.43 to 1.85 | 0.758 | |
| 2.09 | 1.42 to 3.07 | <0.001 | 1.54 | 0.93 to 2.56 | 0.091 | |
| 1.20 | 0.67 to 2.15 | 0.531 | 0.73 | 0.35 to 1.55 | 0.414 | |
| 2.11 | 1.01 to 4.37 | 0.044 | 1.83 | 0.76 to 4.42 | 0.180 | |
| Presence of comorbidities | ||||||
| 4.98 | 3.98 to 6.24 | <0.001 | 1.08 | 0.68 to 1.72 | 0.749 | |
| 0.41 | 0.18 to 0.92 | 0.031 | 0.16 | 0.07 to 0.40 | 0.000 | |
| 5.65 | 4.51 to 7.10 | <0.001 | 4.36 | 2.76 to 6.88 | 0.000 | |
| 7.02 | 0.98 to 50.13 | 0.052 | 4.06 | 0.65 to 25.13 | 0.132 | |
| 5.08 | 1.32 to 19.44 | 0.018 | 0.43 | 0.08 to 2.40 | 0.337 | |
| Village determinants | ||||||
| 0.96 | 0.95 to 0.98 | <0.001 | 0.99 | 0.98 to 1.00 | 0.008 | |
| 1.11 | 1.05 to 1.17 | <0.001 | 1.03 | 0.99 to 1.08 | 0.156 | |
| 3.30 | 1.27 to 8.56 | 0.014 | 14.86 | 0.21 to 10.75 | 0.216 | |
| 0.91 | 0.89 to 0.93 | <0.001 | 0.94 | 0.92 to 0.96 | 0.000 | |
| ICC | 0.37 | 0.28 to 0.46 | ||||
| Likelihood | −1346.11 |
ICC, Intra Class Correlation.
Unadjusted and adjusted multilevel logistic regressions for mortality among patients with COVID-19 (N individual=551, N village=390)
| Variables | Unadjusted OR | 95% CI | P value | Adjusted OR | 95% CI | P value |
| Individual determinants | ||||||
| Age, years, reference: 17 years and younger | ||||||
| 0.51 | 0.10 to 2.58 | 0.420 | 10.52 | 3.29 to 33.59 | 0.000 | |
| 2.62 | 0.59 to 11.52 | 0.201 | 186.00 | 49.32 to 701.39 | 0.000 | |
| 5.32 | 1.17 to 24.10 | 0.030 | 364.22 | 88.57 to 1497.70 | 0.000 | |
| Male | 1.45 | 0.84 to 2.49 | 0.176 | 2.93 | 1.49 to 5.75 | 0.002 |
| Job type, reference: health workers | ||||||
| 0.97 | 0.07 to 12.05 | 0.985 | 0.01 | 0.00 to 0.19 | 0.003 | |
| 0.01 | 0.00 to 0.13 | 0.000 | 0.00 | 0.00 to 0.03 | 0.000 | |
| 0.37 | 0.06 to 2.12 | 0.270 | 1.00 | omitted | ||
| 0.24 | 0.08 to 0.66 | 0.006 | 0.20 | 0.02 to 2.51 | 0.210 | |
| 5.02 | 2.11 to 11.92 | 0.000 | 3.41 | 0.32 to 0.30 | 0.384 | |
| Had contact with confirmed COVID-19 cases | 0.10 | 0.03 to 0.35 | 0.000 | 0.62 | 0.13 to 2.98 | 0.548 |
| Had contact with suspected COVID-19 cases | 0.22 | 0.07 to 0.74 | 0.014 | 0.64 | 0.10 to 3.90 | 0.627 |
| Presence of comorbidities | ||||||
| 2.91 | 1.63 to 5.18 | 0.000 | 1.10 | 0.43 to 4.37 | 0.211 | |
| 2.68 | 0.52 to 13.59 | 0.233 | 1.75 | 0.51 to 5.98 | 0.375 | |
| 2.22 | 1.21 to 4.08 | 0.010 | 17.01 | 5.34 to 54.20 | 0.000 | |
| 24.81 | 2.53 to 242.40 | 0.006 | 2.12 | 0.47 to 9.66 | 0.330 | |
| 18.03 | 6.38 to 50.95 | 0.000 | 30.48 | 13.68 to 67.91 | 0.000 | |
| 8.28 | 1.51 to 45.12 | 0.015 | 12.03 | 2.73 to 53.20 | 0.001 | |
| Medical doctor diagnosis before RT-PCR | ||||||
| 13.07 | 5.99 to 28.53 | 0.000 | 4.75 | 2.33 to 9.65 | 0.000 | |
| 11.16 | 2.43 to 51.13 | 0.002 | 5.99 | 1.23 to 29.17 | 0.027 | |
| 3.05 | 0.78 to 11.84 | 0.106 | 2.12 | 0.81 to 5.54 | 0.127 | |
| Village determinants | ||||||
| 0.99 | 0.99 to 1.00 | 0.252 | 0.98 | 0.97 to 1.00 | 0.008 | |
| 1.00 | 0.96 to 1.04 | 0.833 | 0.96 | 0.90 to 1.03 | 0.251 | |
| 0.59 | 0.28 to 1.22 | 0.162 | 0.97 | 0.00 to 312.57 | 0.306 | |
| 0.99 | 0.96 to 1.02 | 0.660 | 0.99 | 0.92 to 0.98 | 0.513 | |
| 0.99 | 0.97 to 1.01 | 0.507 | 0.70 | 0.95 to 1.02 | 0.909 | |
| 1.01 | 0.95 to 1.07 | 0.715 | 1.45 | 1.02 to 1.51 | 0.031 | |
| ICC | 2.48e-34 | 7.85e-18 | ||||
| −44.31 | ||||||
RT-PCR, reverse transcription PCR.